Surveillance for dysplasia is necessary for patients with ulcerative colitis. CON: Surveillance for ulcerative colitis-associated cancer: Time to change the endoscopy and the microscopy

American Journal of Gastroenterology

Volumn 99, Issue 9, 2004, Pages 1633-1636

  Shanahan, Fergus ^a   Quera, Rodrigo ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BIOLOGICAL MARKER; URSODEOXYCHOLIC ACID;

ANALYTICAL ERROR; BACTERIAL FLORA; CANCER INVASION; CANCER PREVENTION; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL OBSERVATION; COLONOSCOPY; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE COURSE; DYSPLASIA; ENDOSCOPY; GASTROINTESTINAL BIOPSY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HEALTH SURVEY; HISTOPATHOLOGY; HOSPITAL; HUMAN; MEDICAL SPECIALIST; MICROSCOPY; PATHOGENESIS; PATIENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAMPLING; ULCERATIVE COLITIS; BLOOD; COLON TUMOR; COMPARATIVE STUDY; FEMALE; INCIDENCE; IRELAND; MALE; METHODOLOGY; NOTE; PATHOLOGY; PRECANCER; PRIMARY PREVENTION;

BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMANS; INCIDENCE; IRELAND; MALE; MICROSCOPY; PRECANCEROUS CONDITIONS; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 4644268522     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40829_2.x     Document Type: Review

References (36)

1. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451-9.
2. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33.
3. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
4. Ekbom A, Helmick C, Zack M, et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-9.
5. Bernstein CN, Kliewer E, Wajda A, et al. The incidence of cancer among patients with IBD: A population-based study. Cancer 2001;91:854-62.
6. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.
7. Eaden J, Abrams K, Ekbom A, et al. Colorectal cancer prevention in ulcerative colitis: A case-control study. Aliment Pharmacol Ther 2000;14:145-53.
8. Nuako KW, Ahlquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case control study. Gastroenterology 1998;115:1079-83.
9. Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology 2001;120:841-7.
10. Bernstein CN. Challenges in designing a randomized trial of surveillance colonoscopy in IBD. Inflamm Bowel Dis 1998;4:132-41.
11. Shanahan F. Discontent with dysplasia surveillance in ulcerative colitis. Inflamm Bowel Dis 1995;1:80-3.
12. Bernstein CN. Cancer surveillance in inflammatory bowel disease. Curr Gastroenterol Rep 1999;1:496-504.
13. Bernstein CN, Weinstein WM, Levine DS, et al. Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis. Am J Gastroenterol 1995;90:2106-14.
14. Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: An analysis of performance. Gastrointest Endosc 2000;51:123-8.
15. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-20.
16. Bernstein CN. The color of dysplasia in UC. Gastroenterology 2003;124:1135-38.
17. Melville DM, Jass JR, Morson BC, et al. Observer study of the grading of dysplasia in ulcerative colitis. Comparison with clinical outcome. Hum Pathol 1989;20:1008-14.
18. Lewis JD. The many faces of low-grade dysplasia. Gastroenterology 2003;125:1531-8.
19. Ullman T, Croog V, Harpaz N, et al. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 2003;125:1311-9.
20. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
21. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
22. Ransohoff DF, Riddell RH, Levin B. Ulcerative colitis and colonic cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;28:383-8.
23. Taylor BA, Pemberton JH, Carpenter HA, et al. Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-6.
24. Dekker E, Fockens P. New endoscopic tools for the IBD physician. Inflamm Bowel Dis 2004;10(suppl 1):S7-S10.
25. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:1135-8.
26. Fujii S, Fujimori T, Kashida H. Ulcerative colitis-associated neoplasia. Pathol Int 2002;52:195-203.
27. Shanahan F. Relation between colitis and colon cancer. Lancet 2001;357:246-7.
28. Rhodes JM. Lectins, colitis and colon cancer. J R Coll Physicians Lond 2000;34:191-6.
29. Rhodes JM. Unifying hypothesis for inflammatory bowel disease and associated colon cancer: Sticking the pieces together with sugar. Lancet 1996;347:40-4.
30. Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-37.
31. Cordon-Cardo C, Prives C. At the crossroads of inflammation and tumorigenesis. J Exp Med 1999;190:1367-70.
32. Hudson JD, Shoaibi MA, Maestro R, et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999;190:1375-82.
33. Ryan BM, Russel MGVM, Langholz E, et al. Aminosalicylates and colorectal cancer in IBD: A not-so bitter pill to swallow. Am J Gastroenterol 2003;98:1682-7.
34. Bernstein CN, Blanchard JF, Metge C, et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003;98:2784-8.
35. Tung BY, Emond MJ, Haggitt RC, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 2001;134:89-95.
36. Shanahan F. Colitis-associated cancer-time for new strategies. Aliment Pharmacol Ther 2003;18(suppl 2):6-9.